Real-World Data Suggest Acoramidis Outperforms Tafamidis in Heart Amyloidosis
A retrospective US claims analysis found that newly treated ATTR-CM patients starting acoramidis had significantly lower risks of diuretic intensification ...
A retrospective US claims analysis found that newly treated ATTR-CM patients starting acoramidis had significantly lower risks of diuretic intensification ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.